News | Business
27 Apr 2017 23:05
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • News
  • Sport
  • Weather
  • Olympic Games
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Business

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.

    21 March 2017

    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Business News
     27 Apr: Relief over NAFTA helps lift NZ dollar
     27 Apr: Government to spend $11b on infrastructure
     27 Apr: NZ dairy expansion will hit limits
     27 Apr: Air NZ ups capacity on domestic routes
     27 Apr: Rental house conditions sub-par: report
     27 Apr: AWF plays down share spike query
     27 Apr: NZD hits four-month low on Trump tax plan
     Top Stories

    RUGBY RUGBY
    Halfback Hall in as sole Crusaders change More...


    BUSINESS BUSINESS
    Relief over NAFTA helps lift NZ dollar More...



     Today's News

    Rugby:
    Halfback Hall in as sole Crusaders change 21:56

    Rugby:
    Injury-hit Force ring in rugby changes 21:16

    Business:
    Relief over NAFTA helps lift NZ dollar 18:56

    Rugby:
    Wallabies coaches on hand for Waratahs 18:36

    Soccer:
    A-League semi-finals preview panel 18:06

    Law and Order:
    Families 'overwhelmed by kindness' 17:26

    Law and Order:
    Fleeing car closes Dunedin motorway 16:56

    Law and Order:
    Three scenes being examined by police 16:16

    Business:
    Government to spend $11b on infrastructure 16:16

    Accident and Emergency:
    SH1 reopens after Northland crash 15:26


     News Search






    Power Search


    © 2017 New Zealand City Ltd